Key Takeaways
- • Private equity has increasingly deployed nonprofit joint ventures as an expansion strategy across healthcare sectors including hospitals, rehabilitation facilities, ambulatory surgery centers, hospice, home health, and behavioral health services, with the Private Equity Stakeholder Project documenting hundreds of such arrangements.
- • Nonprofit-private equity joint ventures have received significantly less regulatory and public scrutiny than traditional private equity acquisitions despite their growing prevalence, raising questions about existing federal and state oversight frameworks.
- • Joint venture structures enable private equity-backed healthcare companies to expand into new markets, access established referral networks and patient populations, share financial risk with nonprofit partners, and potentially navigate different regulatory considerations than direct acquisitions.
- • The shift toward joint ventures represents an evolution in private equity's healthcare acquisition playbook, driven by strategic advantages that traditional buyout models may not provide in regulated healthcare environments.
Summary
Private equity firms are increasingly leveraging nonprofit joint ventures as a primary mechanism for healthcare expansion, according to research from the Private Equity Stakeholder Project (PESP). The report documents hundreds of healthcare facilities operating under nonprofit-private equity joint venture arrangements—a business model that has proliferated across hospitals, rehabilitation facilities, ambulatory surgery centers, hospice services, home health agencies, and behavioral health providers.
Jim Baker, executive director of PESP, emphasized that this strategic shift represents a meaningful evolution in private equity's healthcare approach: "Private equity's healthcare playbook is evolving. Our research documents how private equity has increasingly relied on joint ventures with nonprofits to expand its presence in healthcare. These arrangements have received far less attention than traditional private equity buyouts, even as they become more common across hospitals and other healthcare sectors."
The joint venture model offers private equity-backed healthcare companies multiple strategic advantages. These partnerships enable expansion into new geographic markets, provide access to established referral networks and existing patient populations, allow risk-sharing with nonprofit co-investors, and potentially face different regulatory treatment than direct acquisitions. The structure appears particularly valuable in healthcare, where regulatory considerations and community stakeholder expectations create friction for traditional leveraged buyouts.
The emergence of this strategy underscores a critical gap in oversight infrastructure. Despite the growing prevalence of nonprofit-private equity joint ventures across the healthcare sector, these arrangements have attracted minimal regulatory attention compared to traditional private equity acquisitions. This asymmetry raises substantive questions about the adequacy of current federal and state oversight frameworks designed to monitor private equity activity in healthcare markets.
Jim Baker, executive director of PESP, emphasized that this strategic shift represents a meaningful evolution in private equity's healthcare approach: "Private equity's healthcare playbook is evolving. Our research documents how private equity has increasingly relied on joint ventures with nonprofits to expand its presence in healthcare. These arrangements have received far less attention than traditional private equity buyouts, even as they become more common across hospitals and other healthcare sectors."
The joint venture model offers private equity-backed healthcare companies multiple strategic advantages. These partnerships enable expansion into new geographic markets, provide access to established referral networks and existing patient populations, allow risk-sharing with nonprofit co-investors, and potentially face different regulatory treatment than direct acquisitions. The structure appears particularly valuable in healthcare, where regulatory considerations and community stakeholder expectations create friction for traditional leveraged buyouts.
The emergence of this strategy underscores a critical gap in oversight infrastructure. Despite the growing prevalence of nonprofit-private equity joint ventures across the healthcare sector, these arrangements have attracted minimal regulatory attention compared to traditional private equity acquisitions. This asymmetry raises substantive questions about the adequacy of current federal and state oversight frameworks designed to monitor private equity activity in healthcare markets.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.